Eversheds Dublin advises Endo Health on $1.7bn takeover of Paladin Labs

The Dublin office of Eversheds has advised on the takeover by Endo Health Solutions of Paladin Labs Europe for approximately $1.7bn (£1.1bn).

The acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target. An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction, and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.

Partners Abigail St John Kennedy, Piaras Power and Darragh Blake and solicitors Darran Nangle and Niamh McMahon from the corporate banking team acted for Endo Health.